Hensel Davest Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Hensel Davest Indonesia Tbk. trades at Rp50 (market cap 76.23B, 3.54M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 7.7× Hensel Davest Indonesia Tbk.'s market cap, and Hensel Davest Indonesia Tbk. is more actively traded (3.54M versus 817.3K). Which is the better fit depends on your goals.
| HDIT | LABS | |
|---|---|---|
Market Cap | 76.23B | 584.6B |
Volume | 3.54M | 817.3K |
Lot | 35.39K | 8.17K |
Turnover | 176.96M | 120.01M |
Average Price | 50 | 146.84 |
Value | 176.96M | 120.01M |
Indicative Equilibrium Price | 50 | 146 |
Indicative Equilibrium Volume | 1 | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Hensel Davest Indonesia Tbk (the Company) was established on January 7, 2013 based on Notarial Deed. 01 from Notary Soewandi Michael Barya Sugiyo SH., M.Kn.
Read more on HDIT →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →